The Impact of mNGS Technology in the Etiological Diagnosis of Severe Pneumonia in Children During the Epidemic of COVID-19

References

• de Benedictis FM, Kerem E, Chang AB, et al. Complicated pneumonia in children. Lancet. 2020;396(10253):786–798. doi:10.1016/S0140-6736(20)31550-6
   PubMed Web of Science ®Google Scholar
• Alamneh YM, Adane F. Magnitude and predictors of pneumonia among under-five children in Ethiopia: a systematic review and meta-analysis. J Environ Public Health. 2020;2020:1606783. doi:10.1155/2020/1606783
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Pneumonia. [Updated November 11, 2021].Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia.
   Google Scholar
• Qian YY, Wang HY, Zhou Y, et al. Improving pulmonary infection diagnosis with metagenomic next generation sequencing. Front Cell Infect Microbiol. 2020;10:567615. doi:10.3389/fcimb.2020.567615
   PubMed Web of Science ®Google Scholar
• Guo W, Cui X, Wang Q, et al. Clinical evaluation of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid collected from children with community-acquired pneumonia. Front Med. 2022;9:952636. doi:10.3389/fmed.2022.952636
   Web of Science ®Google Scholar
• Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011;53:e25–76. doi:10.1093/cid/cir531
   PubMed Web of Science ®Google Scholar
• Faro A, Wood RE, Schechter MS, et al. Official American Thoracic Society technical standards: flexible airway endoscopy in children. Am J Respir Crit Care Med. 2015;191:1066–1080. doi:10.1164/rccm.201503-0474ST
   PubMed Web of Science ®Google Scholar
• Haqqi A, Awan UA, Ahmed H, Afzal MS. Antimicrobial resistance vs COVID-19: a bigger challenge in the post-pandemic era. J Formos Med Assoc. 2021;120(1537–1538):1537–1538. doi:10.1016/j.jfma.2021.03.003
   PubMedGoogle Scholar
• Miller S, Chiu C. The role of metagenomics and next-generation sequencing in infectious disease diagnosis. Clin Chem. 2021;68:115–124. doi:10.1093/clinchem/hvab173
   PubMed Web of Science ®Google Scholar
• Schuele L, Cassidy H, Peker N, Rossen JWA, Couto N. Future potential of metagenomics in microbiology laboratories. Expert Rev Mol Diagn. 2021;21:1273–1285. doi:10.1080/14737159.2021.2001329
   PubMed Web of Science ®Google Scholar
• Su DQ, Huang HL, Zhuo ZQ. Pathogen distribution and bacterial resistance in children with severe pneumonia: a single-center retrospective study. Medicine. 2021;100:e27128. doi:10.1097/MD.0000000000027128
   PubMed Web of Science ®Google Scholar
• Gareca Perales J, Soleto Ortiz L, Loayza Mafayle R, et al. Diagnosis of community-acquired pneumonia in hospitalized children: a multicenter experience in Bolivia. Pediatr Infect Dis J. 2021;40:32–38. doi:10.1097/INF.0000000000002909
   PubMed Web of Science ®Google Scholar
• Wang H, Gu J, Li X, et al. Broad range detection of viral and bacterial pathogens in bronchoalveolar lavage fluid of children to identify the cause of lower respiratory tract infections. BMC Infect Dis. 2021;21:152. doi:10.1186/s12879-021-05834-0
   PubMed Web of Science ®Google Scholar
• Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae Among children hospitalized with community-acquired pneumonia. Clinical infectious diseases: an official publication of the infectious diseases society of America. Clin Infect Dis. 2019;68:5–12. doi:10.1093/cid/ciy419
   PubMed Web of Science ®Google Scholar
• Shim JY. Current perspectives on atypical pneumonia in children. Clin Exp Pediatr. 2020;63:469–476. doi:10.3345/cep.2019.00360
   PubMedGoogle Scholar
• Krafft C, Christy C. Mycoplasma pneumonia in children and adolescents. Pediatr Rev. 2020;41:12–19. doi:10.1542/pir.2018-0016
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shan Y, Cui Y, et al. Characteristics and outcome of severe mycoplasma pneumoniae pneumonia admitted to PICU in Shanghai: a retrospective cohort study. Crit Care Explor. 2021;3:e0366. doi:10.1097/CCE.0000000000000366
   PubMedGoogle Scholar
• Gong H, Sun B, Chen Y, Chen H. The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis. Medicine. 2021;100:e24894. doi:10.1097/MD.0000000000024894
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen Z, Gu W, et al. Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect. 2018;146:1384–1388. doi:10.1017/S0950268818000778
   PubMed Web of Science ®Google Scholar
• Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med. 2021;27:115–124. doi:10.1038/s41591-020-1105-z
   PubMed Web of Science ®Google Scholar
• Hogan CA, Yang S, Garner OB, et al. Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study. Clin Infect Dis. 2021;72:239–245. doi:10.1093/cid/ciaa035
   PubMed Web of Science ®Google Scholar
• van Belkum A, Durand G, Peyret M, et al. Rapid clinical bacteriology and its future impact. Ann Lab Med. 2013;33:14–27. doi:10.3343/alm.2013.33.1.14
   PubMed Web of Science ®Google Scholar
• Kumar S, Garg IB, Sethi GR. Serological and molecular detection of Mycoplasma pneumoniae in children with community-acquired lower respiratory tract infections. Diagn Microbiol Infect Dis. 2019;95:5–9. doi:10.1016/j.diagmicrobio.2019.03.010
   PubMed Web of Science ®Google Scholar
• Copete AR, Vera C, Herrera M, et al. Mycoplasma pneumoniae in children with and without community-acquired pneumonia. What do PCR and serology say? Pediatr Infect Dis J. 2020;39:e104–e108. doi:10.1097/INF.0000000000002636
   PubMed Web of Science ®Google Scholar
• Lin LJ, Chang FC, Chi H, et al. The diagnostic value of serological studies in pediatric patients with acute Mycoplasma pneumoniae infection. J Microbiol Immunol Infect. 2020;53:351–356. doi:10.1016/j.jmii.2018.09.001
   PubMedGoogle Scholar
• Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67:S231–s240. doi:10.1093/cid/ciy693
   PubMed Web of Science ®Google Scholar
• Han D, Li Z, Li R, et al. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019;45:668–685. doi:10.1080/1040841X.2019.1681933
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (FDA). Considerations for Design, Development, and Analytical Validation of next Generation Sequencing (Ngs)–based in vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases. [ Updated April 13, 2018]. Available from: https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM509838.pdf.
   Google Scholar
• Consensus Group Of Experts On Application Of Metagenomic Next Generation Sequencing In The Pathogen Diagnosis In Clinical Moderate And Severe Infections, Professional Committee Of Sepsis And Shock Chinese Research Hospital Association, Professional Committee Of Microbial Toxins Chinese Society For Microbiology et al. 宏基因组学测序技术在中重症感染中的临床应用专家共识(第一版)[Expert consensus for the application of metagenomic next generation sequencing in the pathogen diagnosis in clinical moderate and severe infections (first edition)]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32:531–536. Chinese. doi:10.3760/cma.j.cn121430-20200228-00095
   PubMedGoogle Scholar
• Greninger AL. The challenge of diagnostic metagenomics. Expert Rev Mol Diagn. 2018;18:605–615. doi:10.1080/14737159.2018.1487292
   PubMed Web of Science ®Google Scholar